Detalles de la búsqueda
1.
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV.
Qual Life Res
; 32(2): 531-541, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36512302
2.
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection.
BMC Infect Dis
; 22(1): 428, 2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508986
3.
Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries.
Sex Transm Infect
; 97(8): 566-573, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33632889
4.
Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries.
Sex Transm Infect
; 97(1): 18-26, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732335
5.
Regional differences in perceived treatments needs and priorities in relation to antiretroviral therapy among people living with HIV in 25 countries.
Prev Med
; 142: 106372, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33333128
6.
Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV.
AIDS Behav
; 25(5): 1384-1395, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32748158
7.
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study.
AIDS Behav
; 25(3): 961-972, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33026574
8.
Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe.
Eur J Public Health
; 31(3): 567-575, 2021 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33462616
9.
Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries.
Prev Med
; 139: 106182, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32593732
10.
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.
Health Qual Life Outcomes
; 17(1): 87, 2019 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118091
11.
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
Lancet
; 387(10016): 367-375, 2016 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549466
12.
Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study.
AIDS Behav
; 25(9): 3045, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709213
13.
Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.
Malar J
; 14: 524, 2015 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26702637
14.
The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan.
Vaccines (Basel)
; 12(4)2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675816
15.
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany.
J Med Econ
; 27(1): 39-50, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050685
16.
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.
Infect Dis Ther
; 13(4): 779-811, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498109
17.
Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic.
Vaccine
; 41(29): 4257-4266, 2023 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296016
18.
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States.
J Med Econ
; 26(1): 1532-1545, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37961887
19.
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US.
Open Forum Infect Dis
; 10(7): ofad288, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37496607
20.
Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework.
Front Immunol
; 14: 1204831, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37771594